Newleos Therapeutics has dosed the first participant in its Phase Ib clinical study evaluating NTX-2001, a partial agonist of TAAR1, for AUD.
The post First patient dosed in Newleos’ Phase Ib trial of NTX-2001 appeared first on Clinical Trials Arena.
The Equal Employment Opportunity Commission (EEOC) under the Trump administration is preparing to sue The New York Times over discrimination allegations, the Times reported, a suit …
There is a long-running discussion about the role that religion can play in enhancing personal well-being and lowering the risk of mental health problems
For the first time in its 16-year analysis of the pharma industry, Deloitte found obesity drugs are the largest contributor to late-stage pipeline value, overtaking longtime …
التوازن الغذائي لا يحدد فقط قدرة الجسم على مقاومة الأمراض، بل يؤثر أيضًا على احتمالات حدوث التهابات مزمنة أو اضطرابات مناعية.